For example, CT results demonstrated that IFN-γ sensitized myeloid leukemia cells to alloreactive T cell-mediated killing and could be used as maintenance therapy for patients with relapsed acute myeloid leukemia or myelodysplastic syndrome after allogeneic bone marrow transplantation [152,226]. This evidence concerns the gene IFNG and myelodysplastic syndrome.